The Food and Drug Administration (FDA) approved Pradaxa for release on October 19, 2010 as a prescription blood thinner. Doctors prescribe Pradaxa to patients who have atrial fibrillation in an effort to reduce the occurrence of blood clots. While the drug works to prevent blood clots, it can be equally life threatening.
It might be possible to seek financial compensation if you or a loved one is the victim of a serious injury or death from the internal bleeding associated with Pradaxa. Filing a lawsuit against Boehringer Ingelheim, the manufacturers of Pradaxa, could result in compensation for any physical, financial or emotional injuries. You can contact our firm today and speak with someone about your legal rights.
In addition to being compensated for serious injuries, families of victims who have died may also file a wrongful death suit. The manufacturer's negligence in selling a harmful drug to patients without conducting adequate testing or providing clear warnings can result in a wrongful death suit.
According to research experts, life-threatening internal bleeding has been linked to Pradaxa. During the first quarter of 2011 alone, the FDA received over 500 complaints about Pradaxa. These reports occurred shortly after the drug was approved for market sales by the agency.
Of all the drugs in the same classification group, Pradaxa had the highest number of reported cases, according to the Institute of Safe Medication Practices (ISMP). This organization is responsible for monitoring reports received by the FDA on adverse drug effects.
Some patients who are prescribed Pradaxa have suffered from many complications such as internal bleeding and heart disease. This could be the result of Boehringer Ingelheim failing to issue proper warnings about these complications. The manufacturer should have discovered these dangers through testing prior to selling the drug. The potentially fatal side effects could have been identified had this occurred.
The makers of Pradaxa have a legal responsibility to inform consumers of the possible life-threatening side effects from this drug. FDA requires sufficient testing prior to drug approval for every type of medication sold to the general public. Selling drugs to consumers before testing for potential side effects is complete can lead to serious injuries or even death.
March 6, 2012 - In the Journal of Neurosurgery, researchers highlight the risk associated with hemorrhages from Pradaxa, as the newer blood thinner does not have a “reversing agent” that allows doctors to stop the bleeding.
Contact our firm today if you or a loved one has experienced internal bleeding since taking Pradaxa. You could receive significant compensation as a result of these side effects. We offer a free case evaluation to determine whether you can file a lawsuit against the manufacturers of Pradaxa.